Sitagliptin / Metformin hydrochloride Accord 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - sykursýki, tegund 2 - lyf notuð við sykursýki - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , þrefaldur samsetning meðferð) sem viðbót til að fæði og æfing í sjúklingar ekki nægilega stjórn á eigin hámarks þolað skammt af sjúklingar og sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Fragmin Stungulyf, lausn í áfylltri sprautu með nálarvörn 12.500 and-Xa a.e. 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 12.500 and-xa a.e.

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 12.500 and-xa a.e.

Strefen Munnsogstafla 8,75 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

strefen munnsogstafla 8,75 mg

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg

Fragmin Stungulyf, lausn í áfylltri sprautu með nálarvörn 7.500 and-Xa a.e. 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 7.500 and-xa a.e.

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 7.500 and-xa a.e.

Fragmin Stungulyf, lausn í áfylltri sprautu 15.000 anti-Xa IU 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu 15.000 anti-xa iu

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 15.000 anti-xa iu